18th International Conference On Alzheimer’s Drug Discovery
September 11 - September 12
The purpose for this annual Alzheimer’s Drug Discovery Foundation (ADDF) conference is to accelerate the development of innovative treatments for Alzheimer’s disease, related dementias and cognitive aging.
The two-day meeting is organized around four sub-topics: Neuroinflammation; Neuroprotection and Neural Regeneration; Epigenetics and Cognitive Enhancing; and Misfolded Proteins and Proteostasis.
Attendees will see the diverse cutting-edge approaches ADDF scientists are undertaking and have opportunities for networking and partnership discussions with academic, industry, and foundation thought leaders.